Preclinical Data Supporting the Combination of VS-6766 and Defactinib - J. Silvio Gutkind PhD - Common Questions - UC San Diego @UCSDHealth #headandneckcancer

Preclinical Data Supporting the Combination of VS-6766 and Defactinib - J. Silvio Gutkind PhD - Common Questions - UC San Diego @UCSDHealth #headandneckcancer

User Photo
Cancer-News

1 week
41 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
J. Silvio Gutkind, PhD - UC San Diego discusses Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in Metastatic Uveal Melanoma



AACR


https://investor.verastem.com/news-releases/news-release-details/verastem-oncology-announces-presentation-preclinical-data-0
Up Next Autoplay